George Yancopoulos, EVP, CSO & President, REGN Res Labs at REGENERON PHARMACEUTICALS INC (REGN), sold 27,713 shares at $58.00 ($1.6M) on 2012-01-05, disclosed to the SEC on 2012-01-06.
Scheduled sale ($1.6M) by EVP, CSO & President, REGN Res Labs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| REGN | SELL | 2024-01-04 | $15.2M | — | Filing → |
| REGN | SELL | 2023-03-27 | $5.0M | — | Filing → |
| REGN | SELL | 2023-02-08 | $21.1M | — | Filing → |